How do you pay?

How to pay the least

Ask for the cash price

Voranigo

We didn’t find one.

  1. Ask your pharmacy for Voranigo’s cash price, and one or two other pharmacies too.
  2. Voranigo’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameVoranigo
Authorized genericvorasidenib
Regular genericvorasidenib
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Voranigo?
The original
–
–

Brand nameThe maker’s card

VORANIGO Copay Program (ServierONE)

Savings card from Servier Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on servierone-copay.com 

Or call 1-800-813-5905.

In the maker’s words

“as little as $0 per prescription…”

From the maker’s offer on servierone-copay.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Voranigo itself, from the same company, sold without the brand name, and usually for less. For now Voranigo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VORANIGO is an isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor indicated for the treatment of adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation, as detected by an FDA-approved test, following surgery including biopsy, sub-total resection, or gross total resection.

Source: the FDA label for Voranigo (Servier Pharmaceuticals LLC), June 20, 2026. Full label on DailyMed 

Good to know